🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Algemeen Ziekenhuis Middelheim
Start Date
1993-03
Trial ID
NCT00002517
Small Cell Lung cancer (SCLC) is a highly aggressive tumor that accounts fo...
Status
Completed
Location
Sixth People's Hospital of Luoyang
Start Date
2021-05-20
Trial ID
NCT04660097
The purpose of this study is to test the safety of a combination of two ant...
Status
Completed
Location
Center for Lymphoid Malignancies at CUMC
Start Date
2008-06
Trial ID
NCT00691210
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
This study is aimed to evaluate the progression-free survival(PFS) and also...
Status
Unknown
Location
The First Affiliated Hospital of AnHui Medical University
Start Date
2015-02
Trial ID
NCT02348450
Treatments Being Tested
This Phase 3 study was a randomized, double-blind, placebo-controlled, mult...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2019-07-22
Trial ID
NCT04005716
Treatments Being Tested
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
This phase I/II trial studies the side effects and best dose of melphalan w...
Status
Completed
Location
University of Minnesota/Masonic Cancer Center
Start Date
2005-09-15
Trial ID
NCT00303849
BACKGROUND: * The histone deacetylase (HDAC) inhibitors are a novel class ...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-07-01
Trial ID
NCT00926640
Treatments Being Tested